Item 8.01 Other Events.
On October 19, 2021, VYNE Therapeutics Inc. issued a press release entitled
"VYNE Therapeutics Enrolls First Patient in Clinical Trial of FMX114 for the
Treatment of Mild-to-Moderate Atopic Dermatitis." A copy of the press release is
attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated
by reference herein.
Item 9.01. Financial Statements and Exhibits.
The following exhibit is being filed herewith.
Exhibit No. Description
99.1 Press Release, dated October 19, 2021.
Cover Page Interactive Data File (embedded within the Inline XBRL
© Edgar Online, source Glimpses